» Authors » Michael C Stauder

Michael C Stauder

Explore the profile of Michael C Stauder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 688
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacomina L, Swanson D, Mitchell M, Woodward W, Smith B, Hoffman K, et al.
Int J Radiat Oncol Biol Phys . 2024 Nov; PMID: 39549757
Purpose: Symptomatic locoregionally advanced breast cancer (SLABC) can cause troublesome pain or wound complications that negatively impact quality of life. Although palliative radiation therapy (RT) can minimize tumor-related symptoms, how...
2.
Shaitelman S, Le-Petross H, Raso M, Swanson D, Schalck A, Contreras A, et al.
Int J Radiat Oncol Biol Phys . 2024 Aug; 121(1):90-96. PMID: 39147206
Purpose: Radiation therapy is an underinvestigated tool for priming the immune system in intact human breast cancers. We sought here to investigate if a preoperative radiation therapy boost delivered was...
3.
Stauder M
Int Rev Cell Mol Biol . 2024 Apr; 384:25-46. PMID: 38637098
Inflammatory breast cancer (IBC) is a diagnosis based on a constellation of clinical features of edema (peau d'orange) of a third or more of the skin of the breast with...
4.
Yoder A, Xu T, Youssef P, DeSnyder S, Marqueen K, Isales L, et al.
Pract Radiat Oncol . 2023 Nov; 14(3):e180-e189. PMID: 37914083
Purpose: Dermal backflow visualized on near-infrared fluorescence lymphatic imaging (NIRF-LI) signals preclinical lymphedema that precedes the development of volumetrically defined lymphedema. We sought to evaluate whether dermal backflow correlates with...
5.
Gandhi A, Xu T, DeSnyder S, Smith G, Lin R, Barcenas C, et al.
Breast . 2023 Mar; 68:205-215. PMID: 36863241
Background: We examined how breast cancer-related lymphedema (BCRL) affects health-related quality of life (HRQOL), productivity, and compliance with therapeutic interventions to guide structuring BCRL screening programs. Methods: We prospectively followed...
6.
Reddy J, Lei X, Bloom E, Reed V, Schlembach P, Arzu I, et al.
Int J Radiat Oncol Biol Phys . 2022 Oct; 115(3):629-644. PMID: 36216274
Purpose: Evidence supports use of partial-breast irradiation (PBI) in the management of early breast cancer, but the optimal dose-fractionation remains unsettled. Methods And Materials: We conducted a phase 2 clinical...
7.
Aldrich M, Rasmussen J, DeSnyder S, Woodward W, Chan W, Sevick-Muraca E, et al.
Breast Cancer Res Treat . 2022 Jul; 195(1):33-41. PMID: 35816269
Purpose: Mild breast cancer-related lymphedema (BCRL) is clinically diagnosed as a 5%-10% increase in arm volume, typically measured no earlier than 3-6 months after locoregional treatment. Early BCRL treatment is...
8.
Corrigan K, Lei X, Ahmad N, Arzu I, Bloom E, Chun S, et al.
Adv Radiat Oncol . 2022 Apr; 7(2):100877. PMID: 35387420
Introduction: The first high-quality clinical trial to support ultrahypofractionated whole-breast irradiation (ultra-HF-WBI) for invasive early-stage breast cancer (ESBC) was published in April 2020, coinciding with the beginning of the COVID-19...
9.
Andring L, Diao K, Sun S, Patel M, Whitman G, Schlembach P, et al.
Int J Radiat Oncol Biol Phys . 2022 Mar; 113(3):552-560. PMID: 35248602
Purpose: Patients with breast cancer and ipsilateral axillary and internal mammary (IM) lymph node involvement (cN3b) often forgo IM node resection. Therefore, radiation is important for curative therapy. However, prognosis...
10.
Corrigan K, Woodward W, Stauder M
Chin Clin Oncol . 2022 Jan; 10(6):60. PMID: 35016514
Objective: This review highlights the considerations of the radiation oncologist when managing patients with inflammatory breast cancer (IBC) as well as the radiation oncologist's role as a member of the...